RxDoctor Payments Data

Hiren Makwana

Podiatrist · Lambertville, NJNPI 1538454756

Payments from drug & device makers

$582in general payments, 2019–2025

Across 12 payments — averaging $48.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Rikco International, LLC$176
  • Amgen$126
  • Stryker$125
  • AbbVie$95
  • Boston Scientific$47
  • Treace Medical Concepts, Inc.$14

What the payments were for

  • Food & beverage$40670%
  • Education$17630%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Rikco International, LLC2$176
Amgen(2 entities)4$126
Stryker(2 entities)2$125
AbbVie1$95
Boston Scientific2$47
Treace Medical Concepts, Inc.1$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$582 in reported general payments places this provider in the 45th percentile of 382 podiatrist providers in New Jersey.

See all podiatrist providers in New Jersey

Medicare billing

Part B allowed, 2024
$129,151
Medicare patients
437
Services billed
2,185

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox94$6,162
CiclopiroxCiclopirox Olamine111$2,271
Cephalexin31$700
Ketoconazole13$669
Ammonium Lactate11$132
Methylprednisolone23$105
Silver Sulfadiazine12$71
Meloxicam17$18

Paid to pharmacies, not to this prescriber.

Other podiatrist in Lambertville

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →